<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01600820</url>
  </required_header>
  <id_info>
    <org_study_id>NU146</org_study_id>
    <nct_id>NCT01600820</nct_id>
  </id_info>
  <brief_title>Effect of the Consumption of a Fermented Milk Enriched With Plant Sterols (Spain)</brief_title>
  <official_title>A Randomised, Double-blind, Placebo-controlled, Parallel-group Clinical Study on the Effects of a Fermented Dairy Product Enriched With Phytosterols Over Blood Cholesterol Levels of Hypercholesterolemic Adult Subjects</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Danone Spain</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Danone Research</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to investigate the cholesterol lowering effect of a drinkable
      low fat fermented milk enriched with plant sterol after 3 and 6 weeks in mildly
      hypercholesterolemic subjects treated or not by statins.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>February 2005</start_date>
  <completion_date type="Actual">July 2005</completion_date>
  <primary_completion_date type="Actual">July 2005</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">126</enrollment>
  <condition>Hypercholesterolemia</condition>
  <arm_group>
    <arm_group_label>1 = Tested product 1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>2 = tested product 2</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>3 = Control product</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>1- Low fat drinkable fermented dairy product enriched with 1.6g of plant sterol (as free equivalent) per unit</intervention_name>
    <description>1 = Intervention 1 (1 test product/day)</description>
    <arm_group_label>1 = Tested product 1</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>2- Low fat drinkable fermented dairy product enriched with 2.0g of plant sterol (as free equivalent) per unit</intervention_name>
    <description>2 = Intervention 2 (1 test product/day)</description>
    <arm_group_label>2 = tested product 2</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>3- Low fat drinkable fermented dairy product without plant sterols(control)</intervention_name>
    <description>3 = Intervention 3 (1 control product/day)</description>
    <arm_group_label>3 = Control product</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  male and female aged 18-75 years;

          -  BMI between 19 and 30 kg/m2 ,

          -  LDL-cholesterol higher than 130 mg/dl in individuals with a 10-year risk â‰¤ 20% without
             ischemic cardiopathy; or

          -  higher than 100 mg/dl in individuals with a 10-year risk &gt; 20% or with ischemic
             cardiopathy (according to NCEP ATPIII guidelines),

          -  with or without statin monotherapy,

          -  willing to respect the dietary advising delivered at the screening visit,

          -  agreeing to a written informed consent

        Exclusion Criteria:

          -  subject with plasma triglycerides (TG) levels &gt; 400 mg/dL,

          -  with any cardiovascular event in the last 6 months,

          -  subject taking any drugs affecting lipid metabolism (including hypocholesterolemic
             treatment) other than statin in monotherapy,

          -  diabetic (type I and type II),

          -  presenting known allergy or hypersensitivity to milk proteins, soy or lactose,

          -  receiving systemic treatment or topical treatment likely to interfere with evaluation
             of the study parameters,

          -  with renal failure or any other metabolic disorder which could interfere with efficacy
             or safety assessment of the study,

          -  pregnant or breast feeding women
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Hospital de Sant Joan</name>
      <address>
        <city>Reus</city>
        <zip>43201</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>December 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 15, 2012</study_first_submitted>
  <study_first_submitted_qc>May 16, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 17, 2012</study_first_posted>
  <last_update_submitted>December 6, 2016</last_update_submitted>
  <last_update_submitted_qc>December 6, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 7, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Plant sterol</keyword>
  <keyword>Hypercholesterolemia</keyword>
  <keyword>diet</keyword>
  <keyword>dairy</keyword>
  <keyword>LDL-C</keyword>
  <keyword>Mildly hypercholesterolemic subjects</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypercholesterolemia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

